Cornelius M. Pietzner is CEO and Founder of Alterra Impact Finance. He has had leading roles for 25 years in social impact enterprises, financial management, philanthropy and investments. He served on the Executive Board (CFO) at the Goetheanum, General Anthroposophical Society, Switzerland (2002-2011) responsible for all aspects of finances, with affiliates in 90 countries and approx 8,000 related institutions in education, bio-dynamic agriculture, medicine, socially responsible business and banking. Cornelius is as Trustee/Advisory Board member on various foundations and was a founder of Camphill (life-sharing) Communities/North America.
Alterra invests in initiatives that enhance quality of life and supports European companies through long-term equity capital that meet and foster the basic human necessities of health, food and water.
Alterra Impact Finance GmbH is a Swiss-based investment manager for a Luxembourg SICAV-SIF social impact investment fund. It focuses investments on basic necessities for a human being—health, water and food, in addition to responsible consumer goods which are supportive of the environment. Investments will be made in Europe or with European companies. Investments explicitly include and reward the positive externalities—or impact—of an enterprise through patient and supportive equity investments. These positive social and environmental externalities are central to the overall investment focus of Alterra.
The green/eco and natural lifestyles and markets of the “cultural creatives,” or LOHAS, is diverse, recognized, well established and growing rapidly. Numerous studies attest to the commercial depth of this market segment. The Fund seeks to “do well by doing good,” and can make a distinct and measurable difference in Europe.
The social impact of Alterra’s investee companies supports healthy ecological agricultural practices that restore vitality to the earth and its people and provide meaningful and dignified work opportunities, that clean and remediate water for domestic, agricultural and commerical purposes, and that provide complementary medicine and therapeutic resources that treat the whole person.